PHILADELPHIA, June 17, 2025 /PRNewswire/ -- Integral Molecular, the industry leader in discovering antibodies against membrane proteins, is pleased to announce that it has out-licensed a panel of ...
DES PLAINES, Ill., Feb. 2, 2023 /PRNewswire/ -- Americaneagle.com, a family-owned, global digital agency, and ImmunoProfile, a medical diagnostics company, are proud to jointly announce the launch of ...
Monoclonal antibodies (mAbs) are one of the most successful therapeutic drug classes, generating lucrative sales for the pharmaceutical industry. In 2016, more than 20 therapeutic antibodies gained ...
In this Panel Discussion we assemble experts from across the spectrum of cancer research to explain how they use these techniques in their research, provide key tips for best practice when using them ...
In a study published on the bioRxiv* preprint server, a team of researchers test the neutralizing action of a panel of eight therapeutic monoclonal antibodies (MAbs) against a clinical strain of the ...
NEW YORK (Reuters Health) - A panel of antibodies can accurately detect recent liver-stage Plasmodium vivax infection, researchers report. Current diagnostics cannot detect clinically silent ...
The Food and Drug Administration’s (FDA) antimicrobial drug advisory panel on Thursday voted unanimously in favor of approving a respiratory syncytial virus (RSV) treatment for infants, bringing the ...
The current generation of monoclonal antibodies is ineffective against the predominant variants of SARS-CoV-2 in circulation. Recent studies by Callaway et al. open the possibility that a new type of ...
An FDA advisory committee on Thursday will consider whether to recommend a shot of a monoclonal antibody against respiratory syncytial virus (RSV) to prevent lower respiratory tract disease in both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback